Phosphatidylinositol 3-kinase mediates heregulin-induced growth inhibition in human epithelial cells

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 2197-2200

  Hamburger, Anne W ^a,b   Yoo, Joo Yeon ^a,c  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Breast cancer; ErbB receptors; Heregulin; Phosphatidylinositol 3 kinase

Indexed keywords

GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ARTICLE; ENZYME ACTIVATION; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE C ERB; PHOSPHORYLATION; PRIORITY JOURNAL; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; BREAST; CARRIER PROTEINS; CELL DIVISION; DNA; ENZYME ACTIVATION; ENZYME INHIBITORS; EPITHELIAL CELLS; EPITHELIUM; FEMALE; GLYCOPROTEINS; HUMANS; NEUREGULIN-1; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-3; THYMIDINE;

EID: 0030860487     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M and Lupu R: A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. Cell Growth and Diff 3: 401-411, 1992.
2. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard HM, Kuang WJ, Wood WI, Goeddel DV and Vandlen RL: Identification of heregulin, a specific activator of p185erbB2. Science 256: 1205-1210, 1992.
3. Lupu R, Colomer R, Kannan B and Lippman ME: Characterization of a growth factor that binds exclusively to the erb-2 recepor and induces cellular responses. Proc Natl Acad Sci 89: 2287-2291, 1992.
4. Peles E, Bacus SS, Koski RA, Lu H, Wen D, Ogden SG, Ben Levy R and Yarden Y: Isolation of the neu'HER-2 stimulatory ligand: a 44kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69: 205-216, 1992.
5. Yang Y, Spitzer D, Sachs M, Niemann G, Hartmann G, Weidner KM, Birchmeier C and Birchmeier W: Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 121: 215-226, 1995.
6. Jones FE, Jerry J, Guarino BC, Andrews GC and Stern DF: Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth and Diff 7: 1031-1038, 1996.
7. Peles E, Ben-Levy R, Tzahar E, Nali L Wen D and Yarden Y: Cell- type specific interaction of neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO 12: 961-971, 1993.
8. Slikowski MX, Schaefer G, Axita RW, Lofgran JH, Fitzpatrick D, Nujens N, Ferdly BM, Cerioe RA, Vanden RL and Carraway KL III: Coxpression of erbB2 and erbb3 proteins reconstitute a high affinity receptor for heregulin. J Biol Chem 269: 14661-14665, 1994.
9. erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA 91: 8132-8136, 1994.
10. Chen X, Levkowitz G, Tzahar E, Karunagaran D, Lavi S, Ben-Baruch N, Leitner O, Ratzkin BJ, Bacus SS and Yarden Y: An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErhB-4. J Biol Chem 271: 7620-7629, 1996.
11. Ram TG, Kokeny KE, Dilts CA and Ethier SP: Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulinlike growth factor-1 in human mammary epithelial cells. J Cell Physiol 163: 589-596, 1995.
12. Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD and Sliwkowski MX: Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of erbB2 as a critical component in mediating heregulin responsiveness. Cancer Res 56: 1457-1465, 1996.
13. Carraway KL III, Soltoff SP, Diamonti J and Cantley LC: Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. J Biol Chem 270: 7111-7116, 1995.
14. erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Cell Growth & Diff 7: 551-561, 1996.
15. Fiddes RJ, Janes PW, Sanderson GM, Sivertsen SP, Sutherland RL and Daly RJ: Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells. Cell Growth and Diff 6: 1567-1577, 1995.
16. Kim H-H, Sierke S and Koland JG: Epidermal Growth Factor dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. J Biol Chem 269: 24747-24755, 1994.
17. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, DIFiore PP and Aaronson SA: Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6: 1189-1194, 1992.
18. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y and Matsuda Y: Inhibition of histamine secretion by wortmannin through the blockade of phosphatidyliinositol 3-kinase in RBL-2F cells. J Biol Chem 268: 25846-25856, 1993.
19. Graus-Porta D, Beerli RR and Hynes NE: Single-chain antibody-mediated intracellular retention of erbB-2 impairs neu differentiation factor and epidermal growth factor signaling. Mol and Cell Biol 15: 1182-1191, 1995.
20. Marte BM, Graus-Porta D, Jeschke M, Fabbro D, Hynes NE and Taverna D: NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. Oncogene 10: 167-175, 1995.
21. Riese DJ, Bermingham Y, vanRaaij TM, Buckley S, Plowman GD and Stern DF: Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-B. Oncogene 12: 345-353, 1996.